Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial.

MLA

Livi, Lorenzo, et al. “Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial.” JAMA Oncology, vol. 7, no. 10, Oct. 2021, pp. 1544–49. EBSCOhost, https://doi.org/10.1001/jamaoncol.2021.3395.

APA

Livi, L., Barletta, G., Martella, F., Saieva, C., Desideri, I., Bacci, C., Del Bene, M. R., Airoldi, M., Amoroso, D., Coltelli, L., Scotti, V., Becherini, C., Visani, L., Salvestrini, V., Mariotti, M., Pedani, F., Bernini, M., Sanchez, L., Orzalesi, L., … Meattini, I. (2021). Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial. JAMA Oncology, 7(10), 1544–1549. https://doi.org/10.1001/jamaoncol.2021.3395

Chicago

Livi, Lorenzo, Giuseppe Barletta, Francesca Martella, Calogero Saieva, Isacco Desideri, Carlotta Bacci, Maria Riccarda Del Bene, et al. 2021. “Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial.” JAMA Oncology 7 (10): 1544–49. doi:10.1001/jamaoncol.2021.3395.